Jeff Geschwind, MD is the visionary founder of Cage Pharma. His entrepreneurial spirit focuses on novel cancer drug development, specifically targeting tumor metabolism through glycolysis inhibition. This groundbreaking research offers promising new avenues for treating various aggressive and resistant forms of cancer. https://pairs-society.org/academy_speakers/jeff-geschwind/